Back to Markets
VTvTv Therapeutics Inc

vTv Therapeutics Inc

VTVTNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$33.35

-0.150000 (-0.45%)

As of 05/29/26 EDT · USD

Compare
Low: $14.00Current: $33.35High: $44.00

Key Statistics

Open

$33.50

Day High

$33.50

Day Low

$32.16

Prev. Close

$33.50

VolumeShares traded today.

20.96K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$131.36M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-36.22

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$44.00

52W LowLowest price over the past 52 weeks.

$14.00

50D MAAverage closing price over the last 50 trading days.

$35.51

200D MAAverage closing price over the last 200 trading days.

$30.32

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-6.1%

1M

+6.7%

6M

+19.6%

YTD

-15.8%

1Y

+109.9%

About

Ronald Owen Perelman is an American banker, businessman, investor, and philanthropist. MacAndrews & Forbes Incorporated, his company, has invested in companies with interests in groceries, cigars, licorice, makeup, cars, photography, television, camping supplies, security, gaming, jewelry, banks, and comic book publishing. Perelman holds significant shares in companies such as Deluxe Entertainment, Revlon, SIGA Technologies, RetailMeNot, Merisant, Scantron, Scientific Games Corporation, Valassis, vTv Therapeutics and Harland Clarke. He previously owned a majority of shares in AM General, but in 2020 sold the majority of his shares in AM General along with significant works of art, in light of the impact of the economy on the high debt burdens many of his companies have from leveraged buyouts. In early 2020, Revlon, acquired by Perelman in the 1980s, undertook a debt deal. Previously worth $19.8 billion in 2018, Perelman is, as of November 2022, worth $1.9 billion.

vtvtherapeutics.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade VTVT

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.